Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2006

VistaGen Therapeutics (VSTA) and Sanwa Renew Embryonic Stem Cell Drug Discovery and Development Partnership Focused on New Diabetes Treatments

VistaGen Therapeutics, Inc., a biopharmaceutical company pioneering the use of embryonic stem cells as proprietary biological systems for discovery and development of novel drugs for the treatment of diabetes and central nervous system disorders, announced today the renewal of its … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment